CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ganapathi, M. K.
Right arrow Articles by Kawamura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ganapathi, M. K.
Right arrow Articles by Kawamura, K.

Cell Growth & Differentiation, Vol 7, Issue 7 923-929, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components

MK Ganapathi, AK Weizer, S Borsellino, RM Bukowski, R Ganapathi, T Rice, G Casey and K Kawamura
Cancer Center Experimental Therapeutics Program, Cleveland Clinic Foundation, Ohio 44195, USA.

The role of interleukin 6 (IL-6) in regulating the growth of three human non-small cell lung carcinoma (NSCLC) cell lines (NSCLC-3, NSCLC-5, and NSCLC-7, derived from a primary lesion, a brain lesion, and lymph node metastases, respectively) was examined. Although IL-6 alone did not alter the growth of these cells, the addition of soluble IL-6 receptor (sIL-6R) led to the inhibition of proliferation of one of the NSCLC cell lines, NSCLC-5. This antiproliferative effect was neutralized by antibodies to IL-6 and the IL-6R binding and signaling component (gp130). The IL-6-related cytokines, leukemia inhibitory factor and oncostatin M, inhibited proliferation of NSCLC-5 cells but were ineffective in NSCLC-3 and NSCLC-7 cells. NSCLC-7 cells (but not NSCLC-3 or NSCLC-5 cells) secreted biologically active IL-6 and expressed IL-6R. However, antibodies to IL-6 or gp130 failed to alter the proliferation of NSCLC-7 cells. All three cell lines expressed gp130 mRNA and protein. The level of expression of gp130 protein varied in the three cell lines (NSCLC-7 > NSCLC-3 > NSCLC-5). The examination of tyrosine phosphorylation of gp130 (as an early event in IL-6 signal transduction) revealed that gp130 could be phosphorylated in all cell lines after stimulation with IL-6 and/or IL-6 + sIL-6R. These results demonstrate that the mechanisms responsible for IL-6 resistance in different NSCLC cell lines vary and involve defects at either one or more levels of the IL-6 signaling cascade. In the NSCLC-5 cell line, IL-6 resistance (which can be reversed in the presence of sIL-6R) is due to the transcriptional inactivation of the IL-6R gene. In contrast, in the other two cell lines (NSCLC-3 and NSCLC-7), defect(s) in the signaling cascade downstream of gp130 phosphorylation, together with a lack of expression of IL-6R in NSCLC-3 cells, result in IL-6 resistance.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
R. Minotti, A. Andersson, and M. O. Hottiger
ARTD1 Suppresses Interleukin 6 Expression by Repressing MLL1-Dependent Histone H3 Trimethylation
Mol. Cell. Biol., September 15, 2015; 35(18): 3189 - 3199.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Underhill-Day and J. K. Heath
Oncostatin M (OSM) Cytostasis of Breast Tumor Cells: Characterization of an OSM Receptor {beta}-Specific Kernel.
Cancer Res., November 15, 2006; 66(22): 10891 - 10901.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Tabata, R. Tabata, D. R. Grabowski, R. M. Bukowski, M. K. Ganapathi, and R. Ganapathi
Roles of NF-{kappa}B and 26 S Proteasome in Apoptotic Cell Death Induced by Topoisomerase I and II Poisons in Human Nonsmall Cell Lung Carcinoma
J. Biol. Chem., March 16, 2001; 276(11): 8029 - 8036.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Tabata, R. Tabata, D. R. Grabowski, R. M. Bukowski, M. K. Ganapathi, and R. Ganapathi
Roles of NF-{kappa}B and 26 S Proteasome in Apoptotic Cell Death Induced by Topoisomerase I and II Poisons in Human Nonsmall Cell Lung Carcinoma
J. Biol. Chem., March 16, 2001; 276(11): 8029 - 8036.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.